"SamaCare Raises $17M to Enhance Patient Access Platform for Specialty Medications"

SamaCare's Series B Funding

Key Highlights:

• Series B Funding: Raised $17 million in Series B funding to accelerate product development of its cloud-based patient access platform for specialty medications.
• Investors: Questa Capital led the round, with participation from existing investors Vive Collective and South Park Commons.
• Platform Benefits: SamaCare's platform streamlines specialty drug prior authorization, enrollment, and benefit verification for medical practices, while also providing premium services and data analytics for pharmaceutical brands.

SamaCare's Target Market

• Pharmaceutical Manufacturers: Companies seeking to improve access to therapy and streamline processes related to specialty medications.
• Medical Practices: Specialty practices in fields like retina, oncology, neurology, and rheumatology that handle a significant amount of specialty drug spend.
• Healthcare Payers: Insurance companies and payors interested in optimizing the prior authorization and benefit verification process for specialty medications.

What SamaCare Needs to Buy

• Product Development and Engineering Services: Collaborating with software development and engineering firms to enhance and expand their cloud-based patient access platform.
• Data Analytics and Insights Providers: Partnering with companies specializing in data analytics to further improve their platform's capabilities and provide valuable insights to pharmaceutical brands.
• Marketing and Sales Support: Engaging with marketing agencies and sales experts to effectively promote their platform to pharmaceutical manufacturers, medical practices, and healthcare payers.